Aprovações FDA PMA
Dispositivos com aprovação pré-comercialização acompanhados pelo MedTracker
PMA
2026-09-23
PMA
2026-09-22
Stimulator, spinal-cord, totally implanted for pain relief
Ver detalhes →
PMA
2026-09-22
Stimulator, electrical, implanted, for parkinsonian symptoms
Ver detalhes →
PMA
2026-09-22
Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer
Ver detalhes →
PMA
2026-09-22
Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions
Ver detalhes →
PMA
2026-09-22
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Ver detalhes →
PMA
2026-09-22
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Ver detalhes →
PMA
2026-09-22
Prosthesis, intervertebral disc
Ver detalhes →
PMA
2026-09-21
Unknown Device
Ver detalhes →
PMA
2026-09-21
Immunohistochemistry assay, antibody, programmed death-ligand 1
Ver detalhes →
PMA
2026-09-21
SYSTEM, TEST, HER-2/NEU, IHC
Ver detalhes →
PMA
2026-09-21
Immunohistochemistry Assay, Antibody, Melanoma-associated antigen A4
Ver detalhes →Nenhum dispositivo correspondente.
Página 4 de 80